Abstract 5255: KRAS subtype may modify the poor immunotherapy response in pancreatic cancer: Evidence from early phase trials
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Northwestern University, The Ohio State University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148825398
Cites:
Cited by:
Related to:
